Sign up to save your podcasts
Or
Share Omidenepag: A New Category of Topical Glaucoma Therapy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Omidenepag: A New Category of Topical Glaucoma Therapy
Drs. Amanda Bicket and Lori Provencher join Dr. Andrew Pouw to discuss omidenepag isopropyl (Omlonti), the recently FDA-approved eye drop for treating elevated IOP in patients with primary open-angle glaucoma or ocular hypertension.
For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
View all episodes
By American Academy of Ophthalmology
4.9
5050 ratings
Drs. Amanda Bicket and Lori Provencher join Dr. Andrew Pouw to discuss omidenepag isopropyl (Omlonti), the recently FDA-approved eye drop for treating elevated IOP in patients with primary open-angle glaucoma or ocular hypertension.
For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
More shows like Experts InSight
View all
Ophthalmology off the Grid by Eyetube
43 Listeners
New Retina Radio by Eyetube
17 Listeners
JAMA Ophthalmology Author Interviews
5 Listeners
Eyes For Ears
277 Listeners
CRST: The Podcast
8 Listeners
GT: The Podcast
10 Listeners
Headlight in the fog: The Uveitis Podcast
20 Listeners
Pupil Pod
10 Listeners
RETINA Journal Podcasts
10 Listeners
Talking Euretina
1 Listeners
Ophthalmology Journal
18 Listeners
Mayo Clinic Ophthalmology Podcast
16 Listeners
Cataract Coach with Uday Devgan MD
16 Listeners
Real World Ophthalmology
3 Listeners
ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum
0 Listeners